| 1 |
28830790 | Increased delivery of chemotherapy to the vitreous by inhibition of the blood-retinal barrier. | 2017 Oct 28 |
2 |
| 2 |
21309545 | Double-transduced MDCKII cells to study human P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2) interplay in drug transport across the blood-brain barrier. | 2011 Apr 4 |
1 |
| 3 |
21718946 | Evaluation of the P-glycoprotein- and breast cancer resistance protein-mediated brain penetration of 11C-labeled topotecan using small-animal positron emission tomography. | 2011 Jul |
1 |
| 4 |
19567673 | Compartment-specific roles of ATP-binding cassette transporters define differential topotecan distribution in brain parenchyma and cerebrospinal fluid. | 2009 Jul 15 |
2 |
| 5 |
19047120 | Evaluation of lapatinib and topotecan combination therapy: tissue culture, murine xenograft, and phase I clinical trial data. | 2008 Dec 1 |
2 |
| 6 |
17975156 | P-glycoprotein and breast cancer resistance protein: two dominant transporters working together in limiting the brain penetration of topotecan. | 2007 Nov 1 |
3 |
| 7 |
12089223 | Increased oral bioavailability of topotecan in combination with the breast cancer resistance protein and P-glycoprotein inhibitor GF120918. | 2002 Jul 1 |
2 |
| 8 |
11036110 | Role of breast cancer resistance protein in the bioavailability and fetal penetration of topotecan. | 2000 Oct 18 |
2 |